6,230 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by TFR Capital LLC.

TFR Capital LLC. purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 6,230 shares of the medical equipment provider's stock, valued at approximately $3,252,000. Intuitive Surgical comprises 1.6% of TFR Capital LLC.'s investment portfolio, making the stock its 16th biggest position.

A number of other hedge funds also recently made changes to their positions in ISRG. Norges Bank acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $2,401,493,000. Proficio Capital Partners LLC lifted its stake in shares of Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after purchasing an additional 948,902 shares in the last quarter. Capital Research Global Investors lifted its stake in shares of Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after purchasing an additional 687,906 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of Intuitive Surgical during the fourth quarter worth about $313,769,000. Finally, Northern Trust Corp lifted its stake in shares of Intuitive Surgical by 15.8% during the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after purchasing an additional 494,496 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the firm's stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 32,700 shares of company stock valued at $16,865,621 in the last quarter. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded up $2.22 on Wednesday, reaching $552.41. 1,009,584 shares of the company were exchanged, compared to its average volume of 1,645,420. The company's 50-day moving average is $514.87 and its two-hundred day moving average is $538.30. The firm has a market cap of $197.99 billion, a price-to-earnings ratio of 86.18, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1-year low of $396.15 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the company earned $1.50 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently commented on ISRG shares. Barclays reduced their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Truist Financial reduced their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, Piper Sandler cut their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $596.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.